MENSINGER MIKE (Chief Product Officer) sold 2.4% of their position (4.38K shares) of BETA BIONICS, INC. on the open market
Open‑market sale worth $83.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/3/2026ACC: 0002048500-26-000012
Officer· Chief Product Officer
Since Feb 2026
-4.38K
Net shares
Net seller
$83.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.38K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.38K
Price / share
$19.11
Trade value
$83.62K
% of position
2.4%
9/2/2026
184.41K→180.04K
Total
Net shares
−4.38K
Net value
-$83.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/2/2026 | S · Sale | −4.38K | $19.11 | $83.62K | 2.4% | 184.41K | 180.04K |
| Total | −4.38K | -$83.62K | ||||||
Derivative Transactions0
No derivative transactions reported